A Guide To The Risks Of Investing In Annovis Bio Inc (ANVS)

Anna Perez

Annovis Bio Inc’s filing revealed that its Director Hoffman Michael B acquired Company’s shares for reported $69900.0 on Nov 21 ’25. In the deal valued at $3.50 per share,20,000 shares were bought. As a result of this transaction, Hoffman Michael B now holds 2,490,539 shares worth roughly $9.44 million.

Then, Hoffman Michael B bought 15,000 shares, generating $31,650 in total proceeds. Upon buying the shares at $2.11, the Director now owns 2,470,539 shares.

Before that, Maccecchini Maria-Luisa bought 97,561 shares. Annovis Bio Inc shares valued at $200,000 were divested by the President & CEO at a price of $2.05 per share. As a result of the transaction, Maccecchini Maria-Luisa now holds 1,212,020 shares, worth roughly $4.59 million.

D. Boral Capital downgraded its Annovis Bio Inc [ANVS] rating to a Hold from a a Buy in a research note published recently A number of analysts have revised their coverage, including Maxim Group’s analysts, who increased its forecast for the stock in late October from “a Hold” to “a Buy”. Canaccord Genuity began covering ANVS with “Buy” recommendation on December 29, 2023. Maxim Group maintained its rating on July 07, 2021. It rated ANVS as “a Buy”.

Price Performance Review of ANVS

On Friday, Annovis Bio Inc [NYSE:ANVS] saw its stock fall -2.32% to $3.79. Over the last five days, the stock has gained 61.97%. Annovis Bio Inc shares have fallen nearly -43.26% since the year began. Nevertheless, the stocks have fallen -24.65% over the past one year. While a 52-week high of $7.52 was reached on 01/03/25, a 52-week low of $1.11 was recorded on 04/09/25.

Levels Of Support And Resistance For ANVS Stock

The 24-hour chart illustrates a support level at 3.51, which if violated will result in even more drops to 3.22. On the upside, there is a resistance level at 4.04. A further resistance level may holdings at 4.28.

How much short interest is there in Annovis Bio Inc?

A steep rise in short interest was recorded in Annovis Bio Inc stocks on 2025-10-31, dropping by -0.37 million shares to a total of 1.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 1.4 million shares. There was a decline of -35.36%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.